Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bone Biologics (BBLG) Cash & Equivalents (2016 - 2017)

Historic Cash & Equivalents for Bone Biologics (BBLG) over the last 2 years, with Q3 2017 value amounting to $1.6 million.

  • Bone Biologics' Cash & Equivalents rose 13567.29% to $1.6 million in Q3 2017 from the same period last year, while for Sep 2017 it was $1.6 million, marking a year-over-year increase of 13567.29%. This contributed to the annual value of $620375.0 for FY2016, which is N/A changed from last year.
  • Latest data reveals that Bone Biologics reported Cash & Equivalents of $1.6 million as of Q3 2017, which was up 13567.29% from $783014.0 recorded in Q2 2017.
  • Bone Biologics' Cash & Equivalents' 5-year high stood at $4.2 million during Q1 2016, with a 5-year trough of $620375.0 in Q4 2016.